Tag: GLP-1 analogue
Lilly’s new dual-action diabetes drug causes significant weight reduction
Eli Lilly’s new dual-action diabetes drug shows promise in lowering average blood sugar levels by 2.4% and weight by 12.7% in type 2 diabetes...